In May, Vitrolife announced that Bronwyn Brophy O'Connor had decided to step down as President and CEO to take up the same ...

AstraZeneca’s experimental cancer treatment sone-ve delivered longer survival than analysts had expected in a phase III trial ...

Medical device manufacturers will be spared duplicate certification processes to access the British market. The UK government ...

MEMBER ANNOUNCEMENT - Gruber A/S will join the Danish Pavilion at COMPAMED in Düsseldorf on 16–19 November 2026, with a focus ...

Eli Lilly’s advertising campaign about obesity did not breach industry rules on advertising aimed at the general public, ...

Zealand Pharma has entered into a partnership with American biotech company Generate Biomedicines to develop protein based ...

Biotech company Moderna fell nearly 18 percent on the stock market after study data on the company’s mRNA-based cancer ...

The Swedish medtech company Inossia, which is developing an additive for bone cement, has completed an oversubscribed SEK 88 ...

Pfizer has previously announced a major cost-cutting programme. Now, reports have emerged of job losses at several of the pharmaceutical giant's manufacturing sites in Europe and the US.

Based in Lund, Spago Nanomedical is developing Tumorad, a radionuclide therapy currently being evaluated in a Phase I study ...

A new treatment indication has opened up for AstraZeneca’s Ultomiris following positive results from a phase III trial. The ...

Swedish investment firm EQT is poised to make a major acquisition in the diagnostics sector with a 9.6 billion euro bid for ...